• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background

    Dumping Syndrome Companies

    ID: MRFR/MED/3879-HCR
    115 Pages
    Kinjoll Dey
    October 2025

    Dumping syndrome is a condition characterized by rapid gastric emptying, leading to various symptoms such as nausea, vomiting, abdominal cramps, and diarrhea after consuming a meal. Several companies specialize in developing treatments and solutions for dumping syndrome.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Dumping Syndrome Market

    Dumping syndrome Market

     


    Latest Dumping Syndrome Companies Updates:


    Medtronic's EnteroStim™ System Medtronic received FDA approval for its EnteroStim™ System in early 2023. This neurostimulation device implanted near the pyloric valve delivers electrical pulses to help regulate stomach emptying and potentially reduce dumping syndrome symptoms.


    Gelesis' Plenity® Program Gelesis received FDA approval for its Plenity® Program, a novel dietary management system using swallowable, non-digestible hydrogels to induce a feeling of fullness and potentially manage postprandial symptoms like dumping.


    List of Dumping Syndrome Key companies in the market:



    • Medtronic (U.S.)

    • Intuitive Surgical Inc. (U.S.)

    • TransEnterix Inc. (U.S.)

    • ALLERGAN (Republic of Ireland)

    • USGI Medical Inc. (U.S.)

    • Cousin Biotech (France)

    • GI Dynamics Inc. (U.S.)

    • Johnson & Johnson Services, Inc. (U.S.)